Octagon Research Solutions Sponsors the Pharamceutical Performance Institute
Cross-Organizational Performance Optimization to be Discussed at Groundbreaking Conference
Wayne, PA -- May 16, 2005 -- Octagon Research Solutions, the leader in the electronic transformation of clinical R&D, announced today that it has joined a small yet diverse collection of technology providers to sponsor the Pharmaceutical Performance Institute. The Pharmaceutical Performance Institute (PPI) is comprised of technology leaders that develop innovative solutions for the life sciences industry aimed at improving performance across the organization including regulatory, clinical, contract management, marketing and sales. The group was formed around the idea that technologies and processes must surmount traditional functional barriers in order to gain true efficiencies. The sponsor organizations offer innovative technology solutions that change the way the biopharmaceutical industry works by applying process automation to mission critical events.
"Octagon continues to push the envelope when it comes to performance optimization," states Jim Walker, president and CEO. "We strive to utilize innovative technologies to improve our own performance and we are also committed to sharing our practical expertise with our expanding customer base."
The Pharmaceutical Performance Institute will be hosting the Performance Optimization Conference on July 1, 2005 in New York City. Presenters at the event include pharmaceutical industry thought leaders as well as technology experts in the field of performance optimization.
Walker also notes, "Through well-defined processes, extensive expertise and innovative technologies, we have developed a novel approach to process optimization. The Pharmaceutical Performance Institute provides a perfect forum to share our expertise with leaders of the industry." Mr. Walker will be presenting at the June 1st conference on the topic of "Performance Optimization in the Regulatory Arena."
For more information on the Pharmaceutical Performance Institute, please visit the url: www.octagonresearch.com/ppievent/InvitationMain.html
About Octagon Research Solutions, Inc.
Octagon is a leading process-centric solutions provider that offers a suite of regulatory, clinical, process and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through cross-functional eSub expertise, a holistic process approach, deep domain knowledge and creative use of technology. Octagon is headquartered Wayne, PA, with offices in Boston, MA and Cost Mesa, CA. For more information please visit www.octagonresearch.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
